The partnership aims to improve ESRD patients’ lives and health outcomes while lowering the cost of treatment.
“We are excited to be partnering with Fresenius Medical Care…to prove that through coordinating care we can improve the lives of individuals suffering from end stage renal disease,” Richard Merkin, MD, Heritage’s president and CEO, said in a news release.
More Articles on ACOs:
Specialty ACOs: The Next Step in Accountable Care
Study: ACO Metrics Fall in 6 Main Categories